Single Cell Technology Revenue and Competitors
Estimated Revenue & Valuation
- Single Cell Technology's estimated annual revenue is currently $2.5M per year.
- Single Cell Technology's estimated revenue per employee is $155,000
Employee Data
- Single Cell Technology has 16 Employees.
- Single Cell Technology grew their employee count by 0% last year.
Single Cell Technology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO | Reveal Email/Phone |
2 | Chief Marketing Officer | Reveal Email/Phone |
3 | Research Associate | Reveal Email/Phone |
4 | Data Scientist | Reveal Email/Phone |
Single Cell Technology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Single Cell Technology?
Our antibody discovery platform, AbTheneum, delivers native antibody sequences paired with phenotypic data. We use the best source of immune cells to mine the immune repertoire. We have worked with several pharmaceutical companies over the last decade on numerous discovery campaigns. AbTheneum can screen antibodies upfront for epitope specificity, cross-reactivity, isotype, and several other customized options for your target.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 16 | 7% | $30M |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.3M | 16 | N/A | N/A |
#4 | $1.3M | 16 | N/A | N/A |
#5 | $2.4M | 16 | N/A | N/A |